Modification of MyD88 splicing using modified oligonucleotides
US7879992B2 · kind B2 · utility
33Cited by
8References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 24, 2006 |
| Grant date | Feb 1, 2011 |
| Priority date | — |
| Expiry date | Nov 4, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/345
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Antisense compounds, compositions and methods are provided for modulating the expression of MyD88. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding MyD88. Methods of using these compounds for modulation of MyD88 expression and for treatment of diseases associated with expression of MyD88 are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.